NDC product
Vicks childrens Cough Congestion Night
NDC 37000-712 · The Procter & Gamble Manufacturing Company
Key facts
| Product NDC | 37000-712 |
|---|---|
| Proprietary name | Vicks childrens |
| Nonproprietary name | Phenylephrine Hydrochloride and Diphenhydramine Hydrochloride |
| Substances | DIPHENHYDRAMINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | The Procter & Gamble Manufacturing Company |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC] |
| Marketing start | Apr 22, 2019 |
| Marketing end | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory